RTI Surgical, Inc. shares had a trading volume of 74K on Thursday. Overall, volume was down 77.69% under the stocks normal daily volume.
Short traders are feeling a little more bearish lately if you take into consideration the change in short interest. The stock recorded a rise in short interest between July 31, 2017 and August 15, 2017 of 0.49%. Short interest increased from 1,080,501 to 1,085,809 over that period. Days to cover increased from 3.4 to 4.0 and the percentage of shorted shares was 0.02% on August 15.
Here is a rundown on some insider market activity for RTI Surgical, Inc. (NASDAQ:RTIX). Director Nicholas J. Valeriani acquired 5,500 shares at an average price of $4.70 on August 21st. That brings the Director’s holdings to $224,444 as reported to the SEC.
The following firms have recently changed their position in RTIX. Rock Springs Capital Management Lp added to its position by buying 90,000 shares an increase of 4.8%. Rock Springs Capital Management Lp now controls 1,950,000 shares with a value of $11,408,000. The total value of its holdings increased 53.3%. Ubs Group Ag grew its holdings by buying 105,865 shares an increase of 2,308.9% as of 06/30/2017. Ubs Group Ag now holds 110,450 shares valued at $646,000. The value of the position overall is up by 3,488.9%.
As of quarter end Ancora Advisors, LLC had bought a total of 7,246 shares growing its holdings by 2.9%. The value of the investment in (RTIX) increased from $984,000 to $1,481,000 a change of 50.5% quarter to quarter. As of the end of the quarter Spark Investment Management LLC had acquired 58,500 shares growing its position 57.2%. The value of the investment in RTI Surgical, Inc. went from $408,000 to $940,000 a change of $532,000 for the reporting period.
The company is trading up since yesterday’s close of 4.5. Shares are trading at $4.55 which is just a bit below the 50 day moving average which is $4.92 and just a bit lower than the 200 day moving average of $4.71. The 50 day moving average was down $-0.37 or -7.57% and the 200 day average moved down $-0.16.
In the last earnings report the EPS was $-0.37 and is projected to be $0.06 for the current year with 59,034,000 shares currently outstanding. Next quarter’s EPS is estimated at $0.03 and the next full year EPS is projected to be $0.13.
RTI Surgical, Inc., launched on April 25, 2000, is involved in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Business’s business primarily consists of over six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. The Company processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons..